More details: J&J/Janssen booster. More details:Getting your 2nd dose, Up to Date: Immediately afteryou have receivedthe most recent booster recommended for you It doesn't matter which vaccine you originally received, as long as you haven't gotten a booster yet. You do not need to be revaccinated or receive an additional booster. More details:Staying up to date, At least 2 months after 2nd primary series dose. Centers for Disease Control and Prevention. Always seek the individual advice of your health care provider with any questions you have regarding a medical condition. Centers for Disease Control and Prevention. | Healthcare Associated Infections (HAI). According to CDC data, around 38,000 people have received Novavaxs vaccine as a primary series in the U.S. Linda Yancey, MD, an infectious disease specialist at Memorial Hermann Health System in Southeast Texas, told Verywell that the Novavax shot is another option for people wanting to protect themselves against COVID, and that the shot can be given to people who cannot get other vaccines for medical or accessibility reasons.. It contains pieces (proteins) of the virus that causes COVID (youve heard it called the spike protein). The Novavax vaccine is also authorized as a first booster shot in adults ages 18 and older. About 48% of US adults who are vaccinated haven't received a first booster dose. The mRNA vaccine can be altered quickly, and both Pfizer and Moderna have confirmed an Omicron-specific vaccine is well underway, perhaps as early as the fall. Novavax announced its working on a vaccine against one of the earlier Omicron strains, and Pfizer and Moderna are also targeting Omicron in new vaccines. Examples are tiredness, fever, chills and a headache, which clear up within a couple of days. As with other COVID-19 vaccines, breakthrough cases, in which someone who is vaccinated still gets infected with COVID-19, remain a reality. FDA Authorizes Updated Moderna and Pfizer Booster Shots, What You Need to Know About the New COVID Variant BQ.1.1. Vaccine Equality vs Equity with Dr. Jacinda Abdul-Mutakabbir, Studying Islatravir/Doravirine for HIV Treatment-Nave and Experienced Patients, Vaccine Inequity With Dr. Leonard Friedland. CDC doesnotkeep vaccination records nor determine how vaccination records are used. Data is a real-time snapshot *Data is delayed at least 15 minutes. "Every time a new variant vaccine needs to be made, Novavax is going to have to do a lot of work in the lab to figure out which changes will still allow a good protein to be made and purified at mass quantities.". Heres What We Know, COVID-19 Booster Shots: What You Need to Know, An Overview of the Moderna COVID-19 Vaccine, A Parents Guide to Vaccines for Children, Moderna and Pfizer Share a Peek At Human Data For Bivalent Boosters, Managing Ankylosing Spondylitis During the COVID-19 Pandemic, What to Know About the COVID-19 Vaccine If You Have Diabetes, Psoriasis and COVID-19 Vaccine: What to Know, FDA-authorized mRNA bivalent COVID-19 booster vaccine, U.S. FDA grants emergency use authorization for Novavax COVID-19 vaccine, adjuvanted as a booster for adults, CDC allows Novavax monovalent COVID-19 boosters for adults ages 18 and older, COVID data tracker. There's some data suggesting that certain proteins in the heart look like spike proteinsbut it doesn't look that much like a spike protein, so why certain individuals have more of a reaction than others is still not clear, says Dr. Wilson. Got a confidential news tip? AstraZeneca and Pfizer-BioNTech, as well as the Novavax and . Thats what it is, Dr. Wilson says. Theres a huge amount of infection in the community now, but I think everyone has to set their own level of risk tolerance: How worried are you about catching COVID? For people who got Pfizer's, Moderna's or Novavax's vaccine, that means at least six months have passed since your second shot. How long it takes to build immunity: In clinical trials, one dose of the Moderna vaccine was 80.2% effective a month after vaccination. Because information about COVID-19 changes rapidly, we encourage you to visit the websites of the Centers for Disease Control & Prevention (CDC), World Health Organization (WHO), and your state and local government for the latest information. Novavax's newly authorized booster was developed against the original strain of Covid but the company believes its protein technology provides durable protection across different variants of the virus. Older adults in their 60s and up, or people with underlying health conditions are at higher risk of severe disease and may especially benefit from a booster dose. We don't know yet, Dr. Wilson says. Unvaccinated adults can get Novavax as their primary vaccine. The FDA, in a fact sheet for health-care providers, has warned that Novavax's primary series appears to carry a risk of heart inflammation called myocarditis. Alastair Grant, Associated Press. The FDA authorized a "mix and match" approach to boosters last year. Our New COVID-19 VocabularyWhat Does It All Mean? Johnson & Johnsons Janssen (J&J/Janssen) (CDC recommends that the J&J/Janssen COVID-19 vaccine only be, September 2, 2022, for people aged 12 years and older, October 12, 2022, for people aged 511 years, December 9, 2022, for children aged 6 months4 years who completed the Moderna COVID-19 vaccine primary series. Before the recent authorization, Novavaxs vaccine was only authorized as a two-dose primary series. But importantly, what were counting on the vaccinesfor is to reduce hospitalizations and deaths. CDC has updated select ways to operate healthcare systems effectively in response to COVID-19 vaccination. Is the COVID Vaccine Safe for People With Lung Cancer? The booster dose also induced an immune response in participants who received Moderna, Pfizer and Johnson & Johnson as their primary series, according to the company. COVID data tracker. The new authorization applies to people who've gone at least six months since their primary vaccine and who haven't had any booster yet. Alyssa Hui is a St. Louis-based health and science news writer. Children aged 5 who completed the Pfizer-BioNTech primary series should only get the updated Pfizer-BioNTech booster. Unlike the latest boosters from Pfizer-BioNTech and Moderna, which . According to the FDA, the Novavax booster vaccine is approved for people 18 years of age and older who are six months out from their first two COVID shots. Availability . The results were similar for all ages. The Novavax coronavirus vaccine (brand names:Nuvaxovid andCovovax) is already being used to prevent the coronavirus in 40 other countries, including Canada. Most unsolicited adverse events were also mild-to-moderate in severity; there were no deaths or treatment-related SAEs and 2/298 booster recipients in this analysis reported unrelated SAEs, they wrote.A single booster dose of NVX-CoV2373 demonstrated a satisfactory safety profile, and high levels of neutralizing, anti-S IgG, and hACE2 inhibition antibody responses against the SARS-CoV-2 prototype Wuhan as well as against the Omicron variant including recently emerged sub-variants, the investigators wrote. People who received Pfizer, Moderna or J&J as their primary series can also receive Novavax as. Novavax. All rights reserved. . (Image: AAP) We now have a whole population who have experience with the mRNA vaccines, but theres a group of people who are eagerly waiting for this approval. Pfizer and Moderna also do not have real-world data on how their new boosters perform against BA.5. They help us to know which pages are the most and least popular and see how visitors move around the site. The trial included more than 15,000 participants over the age of 18. Contact: Media Relations Novavax might change your mind. 2023 CNET, a Red Ventures company. T he Food and Drug Administration announced Wednesday that it has authorized a booster shot for Novavax's Covid-19 vaccine. "Some have allergic reactions or more rare concerns like blood clots." The CDC recommends that people stay up to date with their vaccinations and get boosted when eligible. The Novavax vaccine is the fourth one to beauthorized in the United Statesfor the prevention of COVID-19. Yes. The company's shares jumped by almost 6% in morning trading but were flat by noon. We also want multiple production lines that potentially can be updated to address new variants and meet the challenges as they come.. Preliminary Phase II data showed that a single booster of NVX-CoV2373 given six months after an initial two-dose regimen of the same vaccine led to a 4.6-fold increase in antibody titers. The latest experiments suggest that Pfizer's bivalent booster probably won't keep . The CDC has recommended a booster of Novavax's Covid vaccine for adults ages 18 and older. Novavax has been available to adults and teens as young as age 12 as the original or primary vaccine, but this is the first time some people will be able to get it as a booster. These cookies perform functions like remembering presentation options or choices and, in some cases, delivery of web content that based on self-identified area of interests. or risk of disease in a loved one or close contact, A longer time between the 1st and 2nd primary doses may increase how much protection the vaccines offer, and further minimize the rare risk of, You completed a COVID-19 vaccine primary series at least 6 months ago. If you've received your primary vaccine at least six months ago and haven't gotten any other booster, you can get a shot of Novavax. Verywell Health's content is for informational and educational purposes only. Novavax has ongoing trials to study the efficacy of its vaccine as an effective booster against COVID variants like BA.4 and BA.5. All information these cookies collect is aggregated and therefore anonymous. The FDA authorized Novavax's two-dose primary series over the summer in the hope that people who are skeptical of Pfizer's and Moderna's shots would be more willing to get immunized with the Novavax version. CDC is headquartered in Atlanta and has experts located throughout the United States and the world. This may be an advantage when vaccinating harder-to-reach communities where keeping finicky vaccines cool in the fridge may be difficult. People who received Novavax's vaccine as their primary series are also eligible for Pfizer and BioNTech's or Moderna's new omicron booster. Novavax has not presented real-world efficacy data on how its shots perform against BA.5, one of the most immune evasive variants of Covid yet. According to Yancey, a protein subunit vaccine is a purified immunogenic protein which is a viral protein that we know will generate a strong immune response and give high-level protection against the virus., Liu explained that the protein subunit vaccines also contain an ingredient called an adjuvant, which is something that stimulates the immune system to recognize the protein piece as something to form an immune response against, and added that its a much older vaccine technology.. Novavax vaccine works in a different way than the current vaccines. Cookies used to track the effectiveness of CDC public health campaigns through clickthrough data. . The Novavax COVID-19 vaccine (Nuvaxovid) is for people aged 12 and over who wish to have a different COVID-19 vaccine option. CDC is not responsible for Section 508 compliance (accessibility) on other federal or private website. Novavax, in use in the U.S. since mid-2022, warned it may not survive in its latest earnings report, released after the market closed on Tuesday, CNN reported. If the FDA has not approved or authorized a vaccine there may be limited data available or reviewed on the safety or effectiveness of the COVID-19 vaccine. More details:Getting your 2nd dose, Up to Date: 2 weeks after 3rd dose; there is not a recommendation for an updated Pfizer-BioNTech booster for this age group Gavi said it reserves "its rights to recover the advance payments" made to Novavax as part of an Advance Purchase Agreement, in a statement to Reuters, adding that it was unable to comment further due to ongoing legal proceedings. Novavax is a more traditional approach that has been used for long time for other infections, in Hepatitis B and shingles, for example. and as a booster shot in adults. This vaccine is known. The shot was 90% effective at preventing symptomatic Covid and 100% effective at preventing moderate and severe symptoms, U.S.-based Novavax said Monday. A study from the CDC last spring found that Covid infection carries a higher risk of myocarditis than Pfizer or Moderna vaccination. I often tell people, imagine an eggshell without an egg in it. We have been using other vaccines for years that are based on protein subunit technology, including hepatitis B and tetanus.. Novavax's shots rely on more conventional technology used in other vaccines for decades rather than the newer messenger RNA platform used by Pfizer and Moderna. Australia's leading vaccine advisory body has recommended Novavax be used as a COVID-19 booster The Novavax is a protein based shot, unlike previous shots. Information provided in Yale Medicine articles is for general informational purposes only. Spice up your small talk with the latest tech news, products and reviews. Liu said that the Novavax vaccine appears to be safe with few side effects. At the same time, Novavax's expenses have climbed due to the costs of . At least 2 months after 2nd Moderna dose, children aged 6 months4 years can only get a Moderna booster, and children aged 5 years can get a Pfizer-BioNTech or Moderna updated booster. We know they tend to be younger. Novavax is the first protein-based COVID-19 vaccine to be provisionally approved by the Therapeutic Goods Administration (TGA). COVID-19 vaccine recommendations are based on three things: People who are moderately or severely immunocompromised have different recommendations for COVID-19 vaccines. The Centers for Disease Control and Prevention (CDC) cannot attest to the accuracy of a non-federal website. The data demonstrate that the. Others are worried for other reasons, said Liu. These considerations factor into whether we wear a mask or are around a big crowd. If you are age 18 or older and are at least six months from getting your primary COVID-19 vaccine series, you can receive a booster shot from Novavax. Novavax has submitted an application to the Food and Drug Administration for Emergency Use Authorization of its COVID-19 vaccine as a booster in adults that can be used on top of its primary vaccine series or to mix and match with a different primary series, the company announced. More details:Staying up to date. You will be subject to the destination website's privacy policy when you follow the link. Additionally, the vaccine was effective against the Delta variant of concern, Novavax noted in early August. "The mRNA platform is far more modifiable than what Novavax does," he said. However, it is easier to store and ship than mRNA vaccines, he said. They work by teaching our cells to make the protein themselves that will trigger an immune response. Liu noted that the initial data reviewed by the FDA regarding Novavaxs efficacy was collected before Omicron became the predominant COVID variant. Children get a smaller dose of COVID-19 vaccine than teens and adults. This includes segregating the vaccination booths for the two groups of children, two levels of verification on age, and increased training for both registration and vaccination staff. Are we back to where we were before the COVID vaccines? The CDC recommended Novavax's boosters without a debate or vote from its independent experts. Therefore, people who receive a mixed primary series, meaning two different COVID-19 vaccines, have completed the series. More details:Staying up to date, 38 weeks after 1st dose Its not clear whether those cases were caused by the vaccination, Liu said. The maker of the only traditional COVID-19 vaccine still widely available in the United States is raising doubts about its ability to stay in business. More information is available, Travel requirements to enter the United States are changing, starting November 8, 2021. The Food and Drug Administration, in a factsheet for healthcare providers, said adults ages 18 and older can receive Novavax as their third dose six months after completion of the primary series of a U.S. authorized Covid vaccine. The most common side effects of Novavax's vaccine are pain at the injection site, fatigue, headache, muscle pain, nausea and vomiting, according to the Centers for Disease Control and Prevention. Its likely to be a slightly different and more focused vaccine. Novavax COVID-19 vaccine is not currently registered by the TGA for use as a COVID-19 booster vaccine. People ages 12 and older are eligible for Novavax's primary series, while people 18 and over can now get its booster shot. But boosters, in general, have provided more protection to people as the virus continues to mutate and people lose immunity from earlier vaccinations or past infections with COVID-19. In the United States, the Pfizer-BioNTech and the Moderna vaccines ruled as the only authorized COVID-19 boosters. The information contained in this article is for educational and informational purposes only and is not intended as health or medical advice. These cookies allow us to count visits and traffic sources so we can measure and improve the performance of our site. Otherwise, stay up to date by getting the booster recommended for you as soon as a booster is recommended for you based on your age and the appropriate time has passed since completing the primary series. A previous version of the story misstated the eligibility. The updated boosters are called updated because they protect againstboththe original virus that causes COVID-19andthe Omicron variant BA.4 and BA.5. Our website is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Though COVID vaccines may utilize different delivery mechanisms, the end result is the same: cells in the body recognize that a spike protein (the spikes you see sticking out of the coronavirus in pictures) doesnt belong, and the immune system reacts by activating immune cells and producing antibodies to attack the real virus if you get exposed. Novavax applied to the FDA for authorization in January of this year. But theres a good amount of data that shows that boosting immune response with vaccines really does improve the bodys ability to fight BA.5. Read CNBC's latest global health coverage: Correction: People who receive Novavax's vaccine as a primary series are eligible for Pfizer or Moderna's new omicron booster. Always consult a physician or other qualified health provider regarding any questions you may have about a medical condition or health objectives. Two doses brought efficacy up to 95.6%. According to the World Health Organization, "It is impossible to compare vaccines head to head due to the different approaches taken in designing the respective studies.". Offering another vaccine choice may help increase COVID-19 booster vaccination rates for these adults," Novavax CEO Stanley Erck said in a statement Wednesday. In an ad hoc analysis of 298 participants, the short-term safety and immunogenicity of the booster dose was assessed. Published results from a trial found that Novavax's primary vaccine was more than 90% effective against symptomatic COVID-19, and 100% effective against severe disease and death. Myocarditis and pericarditis (inflammation of the heart) are rare side effects of Novavax. Pfizer-BioNTech and Moderna use mRNA technology, and Johnson & Johnson is a viral-vector vaccine. Novavax's Nuvaxovid COVID-19 vaccine has been approved as a booster in people aged 18 and over. She was the 2020 recipient of the Midwest Broadcast Journalists Association Jack Shelley Award. Similar rare reports have risen around the mRNA vaccines, and the FDA has issued awarning labelon both the Pfizer and Moderna vaccines regarding myocarditis and pericarditis in adolescents and young adults. The CDC has signed off on the authorization. People who are 18 and older and are at least six months past their primary COVID-19 vaccine series are eligible to receive Novavax as a booster dose. A Division of NBCUniversal. Previous boosters are called original because they were designed to protect against the original virus that causes COVID-19. Six out of roughly 40,000vaccine recipients developed heart inflammation in a clinical trial with Novavax, compared with one in the placebo group. It was also 93% effective against. Sign up for free newsletters and get more CNBC delivered to your inbox. Furthermore, on October 19, 2022, the FDA amended the Emergency Use Authorization (EUA) to allow for use of the Novavax monovalent COVID-19 vaccine as a first booster at least 6 months after completion of a primary series among persons ages 18 years who are unable or unwilling to receive a bivalent booster. A primary course is 2 doses, 3 weeks apart. A: MOH has introduced stringent procedures at Vaccination Centres to ensure that the correct vaccine and dose are administered. As in other communities, the BA.5 surge locally will peak and eventually have a downturn once the majority of people who are vulnerable, and would be affected, have been affected. The Wall Street Journal: FDA Authorizes Novavax Covid-19 Shot As Booster For Adults. The Novavax COVID-19 vaccine uses more conventional vaccine technology compared to the Pfizer, Moderna, and Johnson & Johnson vaccines. Site by Is Remdesivir Effective Against New COVID-19 Variants? People can update their records with vaccines they received while outside of the United States by: Learn more aboutCOVID-19 vaccination cards. Will Novavax have a longer shelf life in the immune system? Click to share on Facebook (Opens in new window), Click to share on Twitter (Opens in new window), Click to email a link to a friend (Opens in new window), https://www.independent.com/2022/07/19/how-does-novavax-compare-to-pfizer-and-moderna-vaccines/, Santa Barbara Continues Coronavirus Sewage Surveillance, COVID Numbers Are Down, Bringing a New Normal to Santa Barbara, New Omicron Vaccine Arrives to Santa Barbara. The new. An Overview of the Novavax COVID-19 Vaccine, FDA Is Considering Annual COVID Vaccines. This year, new Chief Executive John Jacobs says the company plans to deliver an updated Covid vaccine ahead of the 2023 vaccination . If you do not allow these cookies we will not know when you have visited our site, and will not be able to monitor its performance. On October 19, the U.S. Food and Drug Administration (FDA) authorized the Novavax booster for adults over the age of 18 who are at least six months out from getting their primary COVID vaccine series. Up until now, Novavax's vaccine was only authorized as a two-dose primary series, which limited its market because so many people were already immunized with Pfizer or Moderna. There is not a recommendation to get another updated booster dose. People who got the Valneva booster after a Pfizer vaccine saw only a 30 percent increase above the control group. Trew Knowledge. A committee that advised the FDA to authorize the Novavax vaccine decided the benefits of vaccination outweigh the risks of developing heart inflammation. 2 Teenagers ages 12 through 17 who had the Novavax primary series must get a Pfizer-BioNTech bivalent booster. The American company had previously . Two COVID-19 vaccine manufacturers, Pfizer and Moderna, have developed updated COVID-19 boosters. Staying up to date: If you have completed your primary series, but are not yet eligible for a booster, you are also considered up to date. The rate of myocarditis in clinical trial participants was 0.007% in vaccine recipients and 0.005% in placebo recipients. Medical news, pregnancy topics and health hacks that don't cost money. The company had a contract with the federal government throughOperation Warp Speedbut experiencedmanufacturing problemsthat hindered a speedy emergency use authorization. Some vaccines for influenza, shingles and other ailments use a similar technology. If you got 1 dose of Moderna, Novavax, or Pfizer-BioNTech, it is best to get the same vaccine again to complete the primary series. Centers for Disease Control and Prevention. Pfizer's and Moderna's shots also carry an elevated risk of myocarditis primarily in young men and adolescent boys after the second dose. Now, the Centers for Disease Control and Prevention (CDC) have recommended Novavax's COVID-19 vaccine as a mix-and-match booster dose after a primary series of Pfizer-BioNTech, Moderna, or Johnson & Johnson. U.S. health officials believe Pfizer and Moderna's updated boosters will provide stronger protection against infection and disease this winter than the first generation of vaccines because they target omicron BA.5, which is causing most infections right now. However, certain factors could be reasons to get a vaccine sooner rather than later, such as: COVID-19 vaccine dosage is based on age on the day of vaccination, not on size or weight. Younger men or teen boys have been at higher risk of developing myocarditis or pericarditis after vaccination with an mRNA vaccine, typically after the 2nd dose. The Novavax COVID-19 Vaccine, Adjuvanted (5 g recombinant spike protein/50 g Matrix-MTM adjuvant; NVX-CoV2373) had previously received regulatory authorizations for use in adults 18 years globally.After the primary series of COVID-19 vaccines, the public is being encouraged to get a booster, especially with the impending respiratory virus season upon us. The following information applies to people who want to get different products for their booster vaccine. Myocarditis, a rare form of inflammation of the heart muscle, occurred in a handful of Novavax clinical trial participants, all of whom were men. Dr. Filip Dubovsky, Novavax's chief medical officer, said the company believes its shots will provide durable protection even as the virus continues to evolve. The Australian Technical Advisory Group on Immunisation (ATAGI) has recommended the use of the Novavax vaccine as a booster in Australians aged 18 and over where an mRNA vaccine is not suitable. Its ideal to have more than one or two companies being the sole providers of vaccines, Dr. Wilson says. To find a dose near you, select Novavax from the list and enter your ZIP code. Health experts add that this type of vaccine is safe because the protein thats used is generated in a labthere is no actual virus present in either the vaccine or in the manufacturing process. Novavax booster: You may get a Novavax booster if you are unable or unwilling to receive a Pfizer or Moderna updated COVID-19 booster and you meet the following requirements: You are 18 years of age or older You completed a COVID-19 vaccine primary series at least 6 months ago Prepare and administer the vaccine following manufacturer's guidance which is outlined in CDC's Preparation and Administration summary below. Were enjoying the effect of BA.5 causing a generally less severe surge, in part because so many in our community are vaccinated and boosted. You will need to complete the primary series. More information is available, At least 2 months after 2nd dose or last booster, children aged 5 years, COVID-19 vaccines available abroad that are accepted in the United States as valid vaccinations, Proof of vaccination card in the United States, Recommendations for Fully Vaccinated People, Children and teens aged 6 months17 years, different recommendations for COVID-19 vaccines, people who are more likely to get very sick from COVID-19, people vaccinated outside of the United States, National Center for Immunization and Respiratory Diseases (NCIRD), Possibility of COVID-19 Illness after Vaccination, Investigating Long-Term Effects of Myocarditis, How and Why CDC Measures Vaccine Effectiveness, Monitoring COVID-19 Cases, Hospitalizations, and Deaths by Vaccination Status, Monitoring COVID-19 Vaccine Effectiveness, U.S. Department of Health & Human Services. Updated COVID-19 boosters became available on: If you have received your updated booster dose, you are currently up to date. Shortly after, the Centers for Disease Control and Prevention (CDC) also signed off on the decision. One is that this is an additional vaccine choice that may be acceptable to some of the more than 30% of Americans who are not fully vaccinated, he explains. For people primed with the Pfizer vaccine, a Moderna booster increased antibody levels 11.5 (9.4 to 14.1) times higher than control while a half dose of Valneva increased levels by 1.3 times (99% CI 1.0 to 1.5). Anyone 12 or older can get the Novavax vaccine. Heres everything you need to know about the Novavax COVID booster shot, including how to find out if youre eligible to get it. For purposes of entry into the United States, vaccines accepted will include FDA approved or authorized and WHO Emergency Use Listing vaccines. Updated:Oct. 20, 2022.]. People who've received two original shots and then a booster in 2021 or 2022, for example, aren't eligible right now for an additional boost with Novavax. Nick Blackmer is a librarian, fact-checker, and researcher with more than 20 years experience in consumer-oriented health and wellness content. If you recently had COVID-19, you still need to stay up to date with your vaccines, but youmayconsider delaying your next vaccine dose (whether a primary dose or booster) by 3 months from: Reinfection is less likely in the weeks to months after infection. Lilly to cut insulin prices by 70%, cap prices at $35 per month for people with private insurance, FDA advisors recommend Pfizer RSV vaccine for older adults, despite possible Guillain-Barre risks, Novavax raises doubts about its ability to remain in business, Op-ed: DEA and FDA rules exacerbate Adderall shortage, Democratic attorneys general sue FDA to drop all remaining restrictions on abortion pill, FDA says Guillain-Barre syndrome is possible risk of Pfizers RSV vaccine for older adults, Medicare rejects Alzheimers Association request for unrestricted coverage of treatments like Leqembi, Moderna misses on earnings as costs rise from surplus production capacity, lower demand for Covid shots, West Virginia asks judge to dismiss lawsuit seeking to overturn state restrictions on abortion pill, CDC advisors recommend mpox vaccine for at-risk adults in future outbreaks, Flu vaccine was 68% effective at preventing hospitalization in children, but less protective for seniors this season, Pfizer RSV vaccine that protects infants could receive FDA approval this summer, Senators call on Medicare to offer broad coverage of Alzheimers treatments as public pressure grows, Maker of promising Alzheimers drug Leqembi expects full FDA approval this summer, expanded Medicare coverage.